Risk stratification for early bacteremia after living donor liver transplantation: a retrospective observational cohort study

[1] Chae Min Suk(2018)Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation Liver Transplantation 24 623-633

[2] Moon Kwang Uck(2018)Graft regeneration and functional recovery in patients with early allograft dysfunction after living-donor liver transplantation Ann Transplant 23 481-490

[3] Jung Joon-Yong(2011)Infections in immunocompromised hosts and organ transplant recipients: essentials Liver transpl 17 S34-S37

[4] Choi Ho Joong(2009)Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis Hepatology 51 1445-1449

[5] Chung Hyun Sik(2003)Cirrhosis and bacterial infections Rom J Gastroenterol 12 297-302

[6] Park Chul Soo(2000)Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis Clin Infect Dis 31 1357-1361

[7] Lee Jaemin(2000)Predicting bacteremia and bacteremic mortality in liver transplant recipients Liver Transpl 6 54-61

[8] Choi Jong Ho(2014)Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance J Hepatol 61 1385-1396

[9] Hong Sang Hyun(2013)Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications Liver Int 33 31-39

[10] Chae MS(2018)Management of bacterial and fungal infections in end stage liver disease and liver transplantation: current options and future directions World J Gastroenterol 24 4311-4329

[1] Chae Min Suk(2018)Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation Liver Transplantation 24 623-633

[2] Moon Kwang Uck(2018)Graft regeneration and functional recovery in patients with early allograft dysfunction after living-donor liver transplantation Ann Transplant 23 481-490

[3] Jung Joon-Yong(2011)Infections in immunocompromised hosts and organ transplant recipients: essentials Liver transpl 17 S34-S37

[4] Choi Ho Joong(2009)Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis Hepatology 51 1445-1449

[5] Chung Hyun Sik(2003)Cirrhosis and bacterial infections Rom J Gastroenterol 12 297-302

[6] Park Chul Soo(2000)Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis Clin Infect Dis 31 1357-1361

[7] Lee Jaemin(2000)Predicting bacteremia and bacteremic mortality in liver transplant recipients Liver Transpl 6 54-61

[8] Choi Jong Ho(2014)Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance J Hepatol 61 1385-1396

[9] Hong Sang Hyun(2013)Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications Liver Int 33 31-39

[10] Chae MS(2018)Management of bacterial and fungal infections in end stage liver disease and liver transplantation: current options and future directions World J Gastroenterol 24 4311-4329